rodiyer.idv.tw 拉里拉雜
rodiyer.idv.tw 拉里拉雜
| 問 | What are the criteria for classifying viruses into different risk groups? |
| Whether new variants frequently emerge | |
| ✓ | Whether it affects human health |
| ✓ | Severity of the corresponding infectious disease |
| Transmissibility | |
| ✓ | Availability of effective therapeutic or preventive measures |
| www.rodiyer.com | |
| 問 | Monitoring viruses emerging in nature does not constitute gain-of-function (GOF) research; however, if a potentially high-risk viral strain is detected, it should be reported to the regulatory authori...(以下略) |
| ✓ | 〇 |
| ╳ | |
| www.rodiyer.com | |
| 問 | Viruses with new characteristics generated through serial passaging of a virus are not necessarily all gain-of-function (GOF). |
| ✓ | 〇 |
| ╳ | |
| www.rodiyer.com | |
| 問 | Performing infection experiments in a BSL-3 laboratory is almost the same as in a BSL-2 laboratory, except for wearing additional personal protective equipment. |
| 〇 | |
| ✓ | ╳ |
| www.rodiyer.com | |
| 問 | Even though I have experience handling Risk Group 2 (RG-2) viruses, I must still undergo prior assessment, training, and evaluation to obtain operational qualifications if I want to perform experiment...(以下略) |
| ✓ | 〇 |
| ╳ | |
| www.rodiyer.com | |
| 問 | Performing infection experiments inside a biosafety cabinet is primarily to ensure that the cells used in my experiment do not get contaminated. |
| 〇 | |
| ✓ | ╳ |
| www.rodiyer.com | |
| 問 | The experimental methods and workflows I use for Risk Group 2 (RG-2) viruses in a BSL-2 laboratory can be identically applied to Risk Group 3 (RG-3) viruses in a BSL-3 laboratory. |
| 〇 | |
| ✓ | ╳ |
| www.rodiyer.com | |
| 問 | Since we don't know the outcome, experiments involving viral modification can be performed first, and a biosafety permit can be applied for after the results show that the modified virus has gained fu...(以下略) |
| 〇 | |
| ✓ | ╳ |
| www.rodiyer.com | |
| 問 | Which of the following can be considered methodologies for viral gain-of-function (GOF) research that require enhanced assessment during biosafety applications? |
| ✓ | Generation of chimeric viruses |
| Removal of specific viral genes | |
| ✓ | Site-directed modification of the viral genome |
| Application of inhibitory drugs in a single-round infection experiment | |
| ✓ | Serial passaging of the virus under inhibitory drug treatment of infected cells |
| www.rodiyer.com | |
| 問 | Which of the following is not an appropriate justification for performing viral functional modification experiments? |
| To understanding the function of viral genes | |
| ✓ | To prove that the research group is capable of modifying viruses |
| To develop new antiviral drugs | |
| ✓ | To enhance the impact of research results |
| To investigate the transmission mechanisms of the virus |
沒有留言: